Einträge von Harbeck, Nadia auf dem Publikationsserver

Hartkopf, Andreas D., Brucker, Sara Y., Taran, Florin-Andrei, Harbeck, Nadia, von Au, Alexandra, Naume, Bjørn, Pierga, Jean-Yves, Hoffmann, Oliver, Beckmann, Matthias W., Rydén, Lisa, Fehm, Tanja, Aft, Rebecca, Solà, Montserrat, Walter, Vincent, Rack, Brigitte, Schuetz, Florian, Borgen, Elin, Ta, Minh-Hanh, Bittner, Ann-Kathrin, Fasching, Peter A., Fernö, Mårten, Krawczyk, Natalia, Weilbaecher, Katherine, Margelí, Mireia, Hahn, Markus, Jueckstock, Julia, Domschke, Christoph, Bidard, Francois-Clement, Kasimir-Bauer, Sabine, Schoenfisch, Birgitt, Kurt, Ayse G., Wallwiener, Markus, Gebauer, Gerhard, Klein, Christoph A., Wallwiener, Diethelm, Janni, Wolfgang und Pantel, Klaus (2021) Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis. European Journal of Cancer 154, S. 128-137. Volltext nicht vorhanden.

Werner-Klein, Melanie, Grujovic, Ana, Irlbeck, Christoph, Obradović, Milan, Hoffmann, Martin, Koerkel-Qu, Huiqin, Lu, Xin, Treitschke, Steffi, Köstler, Cäcilia, Botteron, Catherine, Weidele, Kathrin, Werno, Christian, Polzer, Bernhard, Kirsch, Stefan , Gužvić, Miodrag, Warfsmann, Jens, Honarnejad, Kamran, Czyz, Zbigniew, Feliciello, Giancarlo, Blochberger, Isabell, Grunewald, Sandra, Schneider, Elisabeth, Haunschild, Gundula, Patwary, Nina, Guetter, Severin, Huber, Sandra, Rack, Brigitte, Harbeck, Nadia, Buchholz, Stefan, Rümmele, Petra, Heine, Norbert, Rose-John, Stefan und Klein, Christoph A. (2020) Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency. Nature Communications 11, S. 4977.

Gluz, Oleg, Wild, Peter, Liedtke, Cornelia, Kates, Ronald, Mendrik, Heiko, Ehm, Elisabeth, Artinger, Verena, Diallo-Danebrock, Raihanatou, Ting, Evelyn, Mohrmann, Svjetlana, Poremba, Christopher, Harbeck, Nadia, Nitz, Ulrike, Hartmann, Arndt und Gaumann, Andreas (2011) Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial. Breast Cancer Research and Treatment 126 (3), S. 643-651. Volltext nicht vorhanden.

Lux, Michael P. , Wöckel, Achim, Benedict, Agnes, Buchholz, Stefan, Kreif, Noémi, Harbeck, Nadia, Kreienberg, Rolf, Kaufmann, Manfred, Beckmann, Matthias W., Jonat, Walter, Hadji, Peyman, Distler, Wolfgang, Raab, Guenther, Tesch, Hans, Weyers, Georg, Possinger, Kurt und Schneeweiss, Andreas (2010) Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System. Onkologie 33 (4), S. 155-166. Volltext nicht vorhanden.